摘要
Introduction: Diabetic kidney disease (DKD) has become a global public health problem with a significant disease burden. A number of Chinese patent medicines (CPMs) are widely used in the treatment of DKD in China. An overview of systematic reviews (SRs) can summarize the overall evidence of its effectiveness and safety for both practice and research. Methods: SRs and/or meta-analyses based on randomized controlled trials (RCTs) of oral CPMs for DKD were identified. Eight databases were searched from their inception to October 2021. The AMSTAR 2 tool was applied to appraise the methodological quality of the included SRs by two authors. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach was used to summarize the certainty of evidence of the included reviews. Results: A total of 88 SRs were included, of which three were published as abstracts only (quality not assessed). The methodological quality using the AMSTAR 2 approach was assessed as "low" for five SRs and "critically low" for 80 SRs. Renal end-point events and quality of life were not reported in all SRs. Most of the reviews reported surrogate outcomes. Serum creatinine and 24 h urinary total protein were the two most commonly reported indicators, and regrettably, no high-quality evidence with GRADE assessment was found. Regarding safety, except for Tripterygium glycosides tablet which had several adverse effects, other CPMs had only mild adverse effects. Conclusion: Due to the lack of end-point outcomes and high-quality evidence, the effectiveness and safety of oral CPMs for DKD remain uncertain. Future studies with more critical methodological designs are needed to provide
学科与关键词
- Renal-protective effects of Chinese medicinal herbs and compounds for diabetic kidney disease in animal models: protocol for systematic review and meta-analysisLiu, Meifang; Di, Yuan Ming; Zhang, Anthony Lin; Chen, Junhui; Wang, Ruobing; Huang, Juan; Zhang, Lei; Xue, Charlie Changli*; Liu, Xusheng*Systematic Reviews, 2024, 13(1): 23.
- Effectiveness comparisons of traditional Chinese medicine on treating diabetic nephropathy proteinuria: A systematic review and meta-analysis.Wang, Lin; Wang, Ya-Hui; Zhang, Xian-Hui; Yang, Xue-Lian; Wei, Hui-Li; An, Zhi-Chao; Yu, Bo-Rui; Du, Da-Qing; Guo, Yan; Liu, Hong-FangMedicine (Baltimore), 2019, 98(43): e17495.
- Oral Chinese Herbal Medicine plus usual care for diabetic kidney disease: study protocol for a randomized, double-blind, placebo-controlled pilot trialLiu, Meifang; Di, Yuan Ming; Zhang, Lei; Yang, Lihong; Zhang, La; Chen, Junhui; Wang, Ruobing; Xie, Xiaoning; Lan, Fang; Xie, Liping; Huang, Juan; Zhang, Anthony Lin; Xue, Charlie Changli*; Liu, Xusheng*Frontiers in Endocrinology, 2024, 15: 1334609.
